Use of Mouse Models To Evaluate the Persistence, Safety, and Immune Modulation Capacities of Lactic Acid Bacteria
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Recent clinical and experimental observations showed that specific probiotic microorganisms may provide therapeutic benefits in inflammatory bowel disease. However, a rigorous screening for new candidate probiotic strains with optimized therapeutic properties necessitates also determining possible adverse interactions with the host, particularly in individuals who are not healthy. We have evaluated the persistence of strains of lactic acid bacteria (LAB) in the digestive tracts of mice, their immunomodulation capacity, and their safety in healthy animals and in a colitis model. Following daily administration of 10 9 CFU of viable LAB orally, intragastrically, or intrarectally, the animals' feces were examined for bacterial excretion and cytokines were quantified in intestinal samples by quantitative reverse transcription-PCR. The level of bacterial translocation was assessed in healthy mice and in mice suffering from colitis induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS). Irrespective of the route of administration, the potential probiotic strain Lactobacillus plantarum NCIMB8826 was found to persist for up to 10 days in the digestive tracts of mice. This strain did not induce detrimental effects in healthy or in TNBS-treated animals, as was reflected by the absence of weight loss, intestinal inflammation, modification of cytokine levels in the ileum and colon (healthy mice), and bacterial dissemination (healthy and colitic animals). Moreover, the translocation of endogenous microflora to the mesenteric lymph nodes and spleen was greatly reduced in the TNBS-treated mice after administration of LAB. This property, together with the strain's persistence capacity and innocuousness renders L. plantarum NCIMB8826 an attractive candidate as a probiotic to be used in the prevention or treatment of chronic inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dunne, C., O’Mahony, L., Murphy, L., Thornton, G., Morrissey, D., O’Halloran, S., Feeney, M., Flynn, S., Fitzgerald, G., Daly, C., et al. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.386s · Cited by 922 · cited 4×
“This colitis model was used, as it results in severe colonic inflammation similar to that described for patients with IBD (31).”
BackgroundInfluentialProbiotic immunomodulation in health and disease
Erickson, K. L., & Hubbard, N. E. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.403s · Cited by 372
Lactobacillus bacteremia and endocarditis: Review of 45 cases
Husni, R. N., Gordon, S. M., Washington, J. A., & Longworth, D. L. (1997) · Clinical Infectious Diseases · doi:10.1086/516109 · Cited by 270 · cited 1×
“Even though dietary LAB benefit from the GRAS (generally recognized as safe) status, some reports have identified Lactobacillus species associated with bacteremia or endocarditis (1, 3, 16, 24, 30, 48).”
BackgroundVesa, Pochart, & Marteau (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00763.x · Cited by 200 · cited 3×
“Our laboratory selected the human isolate Lactobacillus plantarum NCIMB8826 as a promising probiotic strain based, on the one hand, on its technological properties and, on the other hand, on its ability to survive passage through the human stomach (47) and to induce secretion of anti-inflammatory cytokines by peripher…”
BackgroundMethodResult
Cited by
Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens
Servin, A. L. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.01.003 · Cited by 1,236
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,052
de Vries, M. C., Vaughan, E. E., Kleerebezem, M., & de Vos, W. M. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2005.09.003 · Cited by 514
van Zyl, W. F., Deane, S. M., & Dicks, L. M. T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1831339 · Cited by 340
Safety of probiotics: translocation and infection: Nutrition Reviews©, Vol. 66, No. 4
Liong, M.-T. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00024.x · Cited by 265
Metadata
- Authors
- Pavan, S., Desreumaux, P., & Mercenier, A.
- Venue
- Clinical and Vaccine Immunology
- Publisher
- American Society for Microbiology
- Published
- 2003-07
- Volume
- 10
- Issue
- 4
- Pages
- 696-701
- ISSN
- 1556-679X (ISSN-L)
- 1556-6811
- OpenAlex
- W2113379278
- Cited by
- 138
- References
- 4
- FWCI
- 12.11
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Mouse Models To Evaluate the Persistence, Safety, and Immune Modulation Capacities of Lactic Acid Bacteria. https://app.cochat.ai/papers/10.1128/cdli.10.4.696-701.2003
- The paper
- Pavan, S., Desreumaux, P., & Mercenier, A. (2003). Use of Mouse Models To Evaluate the Persistence, Safety, and Immune Modulation Capacities of Lactic Acid Bacteria. Clinical and Vaccine Immunology. https://doi.org/10.1128/cdli.10.4.696-701.2003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.